(untitled)

Fernando J. Martínez(University of Massachusetts Chan Medical School), Ruth Tal‐Singer, Paul Dorinsky(AstraZeneca (France)), Bartolomé R. Celli(Brigham and Women's Hospital), Hana Müllerová(AstraZeneca (United Kingdom)), MeiLan K. Han(University of Michigan), Patrick Darken(AstraZeneca (Brazil)), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Nicholas Locantore(Research Triangle Park Foundation), Robert A. Wise(Johns Hopkins University), David Halpin(University of Exeter), Mark T. Dransfield(University of Alabama at Birmingham), Surya P. Bhatt(University of Alabama at Birmingham), Gavin C. Donaldson(Boehringer Ingelheim (Egypt)), David Price(Optimum Therapeutics (United States)), Àlvar Agustí(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Rosa Faner(Instituto de Salud Carlos III), Fernando D. Martínez(University of Arizona), Sanjay H. Chotirmall(Nanyang Technological University), Claus Vogelmeier(German Center for Lung Research), James P. Allinson(Royal Brompton Hospital), Jerry A. Krishnan(Chicago Department of Public Health), Dave Singh(Manchester University NHS Foundation Trust), Colin Reisner(Reproductive Medicine Associates of New Jersey), Jørgen Vestbo(Manchester Academic Health Science Centre), Badrul A. Chowdhury, Paul Jones(Royal London Hospital), Peter Calverley(University of Liverpool), Carla A. Da Silva(AstraZeneca (Netherlands))
Research Explorer (The University of Manchester)
January 1, 2000
Cited by 130


Related Papers